Histological correlates of hippocampal magnetization transfer images in drug-resistant temporal lobe epilepsy patients

1. Introduction

Hippocampal sclerosis (HS) is the most common pathological finding in adults with drug-resistant epilepsy ⁴. In the pathological evaluation, HS is characterized by differential neuron loss, often more severe in CA1 and CA4 ⁵. Besides neuron loss, gliosis and changes in extracellular matrix proteins are seen in the sclerotic hippocampus of these patients ^{8; 25; 26; 37}. Moreover, gliosis can even be seen in the hippocampi of temporal lobe epilepsy patients (TLE) without neuron loss ³⁴. The presurgical magnetic resonance imaging (MRI) of these patients often shows hippocampal volume loss and increased T2 signal ^{2; 6; 7}. However, in up to 15 % of the TLE patients, no abnormalities are observed in the standard MR evaluation ^{3; 17}. Although the normal MRI patients often have only milder or no neuron loss, some can have neuron loss and other pathological changes as severe as those cases with hippocampal sclerosis detected on MRI ^{17; 25}. Since the presence of HS is often an indicator of good surgical outcome in TLE ^{5; 34}, it is crucial for improving the pre-surgical detection of those MRI-negative cases with pathologically proven HS, as well as more subtle pathological changes in the hippocampus.

New quantitative MRI techniques could improve the detection of more subtle abnormalities seen in epilepsy patients ¹¹. Magnetic transfer (MT), an imaging protocol that evaluates macromolecules not visible in either T1-weighted or T2-weighted images, is often reduced in regions with EEG abnormalities with normal conventional MRI ²⁹. While some studies have indicated the association between myelin loss and MTR reduction in the white matter, and between neuron loss and MTR reduction in the cerebral cortex, there remains to be determined which pathological changes are responsible for the decreased hippocampal MTR in TLE patients. We recently found that extracellular matrix chondroitin sulfate proteoglycan (CSPG) could impact both hippocampal volume ²⁵ and T2 signal relaxation time ²⁴. Since MTR is influenced by the macromolecules present in the tissue, our objective was to evaluate the correlations between the MTR and chondroitin sulfate, as well as with cellular populations, in the hippocampus of drug-resistant temporal lobe epilepsy patients.

2. Materials and Methods

3. Results

3.2. MRI Evaluation

The automatic hippocampal analysis showed no significant difference in hippocampal volume between controls and TLE cases (p = 0.104; Figure 1 A). Only nine of the TLE patients (34.6 %) had hippocampal atrophy, following the cutoffs of previous quantitative studies with a different set of cases ²⁵. Hippocampus from TLE patients presented with higher relaxation time than controls (p < 0.001; Figure 1 B). The hippocampi from TLE cases had a significant reduction in MTR compared to controls (p < 0.001; Figure 1 C). Based on control hippocampi average and standard deviation, cases below 95% MTR of controls (i.e., below 48.6 % magnetization transfer) were classified as having low MTR, and those above as having normal MTR. In the patients without hippocampal volume loss, the low MTR was seen in 50 % of cases. As for the cases with hippocampal atrophy, 88 % had low MTR. The combination with T2 relaxation increases the detection of the abnormal hippocampus to 64 % of normal volume cases.

• Download figure
• Open in new tab

Figure 1.

Quantitative magnetic resonance evaluation of the hippocampi from controls (radiological controls, blue boxplots) and TLE patients (red boxplots). (A) There was no difference between controls and ipsilateral (dark red boxplot) or contralateral (light red boxplot) hippocampi from TLE regarding volume. (B) Only the ipsilateral hippocampus of TLE patients presented with increased T2 relaxation time and (C) reduced magnetization transfer, when compared to controls. There was no difference between the ipsilateral and contralateral hippocampus of TLE cases. The asterisks indicate statistical difference, the line inside the boxplots indicate median and the dot indicate mean.

3.3. Cellular Populations and Extracellular Matrix

TLE patients had lower neuron density than controls in CA4, CA3, CA2, and CA1 (p < 0.001), with no difference in the subiculum (p = 0.57; Figure 2 A). Reactive astrogliosis was seen in CA1 (p = 0.001) and in the subiculum (p = 0.002; Figure 2 B) of TLE cases, compared to controls. Activated microglia was present in CA4 (p = 0.012), CA3 (p = 0.004), CA2 (p = 0.003), and in CA1 (p < 0.001; Fig. 2 C) of TLE patients, compared to controls. Increased expression of chondroitin sulfate proteoglycan was seen in all hippocampal subfields evaluated (p < 0.001; Figure 2 D). A representative image showing the expression patterns in TLE is shown in Figure 3.

• Download figure
• Open in new tab

Figure 2.

Semi-quantitative evaluation of hippocampal sections from controls (histological controls, blue boxplots) and TLE patients (red boxplots) submitted to immunohistochemistry. (A) All hippocampal subfields but the subiculum of TLE cases presented with neuron loss. (B) Only CA1 and the subiculum of TLE had significant astroglial reaction, when compared to controls. (C) Following the neuron density changes, all hippocampal subfields but the subiculum had activated microglia, when compared to controls. (D) Chondroitin sulfate proteoglycan was seen in higher levels in all hippocampal subfields of TLE cases, compared to controls. The asterisks indicate statistical difference, the line inside the boxplots indicate median and the dot indicate mean.

• Download figure
• Open in new tab

Figure 3.

Representative immunohistochemistry micrographs of the pathological changes seen in the CA1 subfield from TLE samples. (A) NeuN staining, showing reduced neuron density in TLE CA1. (B) GFAP staining showing fibrous astrogliosis, as defined by ILAE, in a TLE case. Two reactive astrocytes are indicated by arrows. (C) Increased activation of microglial cells, marked by the expression of MHC class II HLA-DR protein. One activated microglia is pointed by the black arrow. (D) Fibrous aggregates of extracellular chondroitin sulfate proteoglycans, showed by CS-56 antigen immunohistochemistry. The bar in (D) indicates 100 µm.

3.4. Associations between MRI, clinical data, and histology

Hippocampal MTR were not significantly different regarding HS type, the presence of secondarily generalized seizures, the occurrence of status epilepticus or seizures in clusters, a positive familial history of seizures, seizure frequency, occurrence of IPI, or surgical outcome (see Table 1). Logistic regression with the MTR classification (low vs. normal) reinforced the lack of association between MTR and the clinical data.

Hippocampal MTR correlated positively with neuron density in CA3 (R = 0.581, p = 0.0059; Figure 4 A) and with CSPG levels in CA4 (R = 0.513, p = 0.0291), CA3 (R = 0.66, p = 0.0038; Figure 4 B), CA2 (R = 0.486, p = 0.0297), CA1 (R = 0.544, p = 0.0109; Figure 4 C), and in the subiculum (R = 0.578, p = 0.0182; Figure 4 D). Negative correlations between hippocampal MTR and activated microglia were seen in CA3 (R = −0.566, p = 0.0175), CA2 (R = −0.636, p = 0.0079), and in CA1 (R = - 0.604, p = 0.0103). Reactive astrocytes had no correlation with MTR. A 3D visualization of neuron density, chondroitin sulfate, and MTR can be seen, respectively, in Supplementary Figures 1 and 2.

• Download figure
• Open in new tab

Figure 4.

Scatterplot and regression between histological and magnetization transfer data of TLE patients. Whole hippocampal MTR from TLE cases correlated positively with neuron density in CA3 (A) and with chondroitin sulfate levels in CA3 (B), CA1 (C), and the subiculum (D).

From different combinations of neuron density and CSPG levels in CA4, CA3, CA1, and the subiculum, the best multiple linear model for explaining the variation in hippocampal MTR were the combination of neuron density and CSPG in CA3 and CA1, with a overall predictive value of 71 % for the MTR (R = 0.841, R² = 0.708, VIF < 2.971, p = 0.006). The following equation was given for these variables:

MTR = 40.282 + (0.324 × neuron density in CA3) - (0.274 × neuron density in CA1) + (0.0750 × CSPG levels in CA3) + (0.0429 × CSPG levels in CA1)

Individually, the changes in CA3 explain 59 % of the hippocampal MTR (R = 0.767, R² = 0.588, VIF = 1.049 p = 0.003), whereas CA1 explains 43 % of MTR (R = 0.652, R² = 0.426, VIF = 1.035, p = 0.009). The multiple linear regression equations are as follows:

MTR = 39.779 + (0.349 × neuron density in CA3) + (0.100 × CSPG levels in CA3) MTR = 43.487 - (0.131 × neuron density in CA1) + (0.0943 × CSPG levels in CA1)

4. Discussion

Reduced hippocampal volume and increased T2-weighted signal are important hallmarks of the epileptogenic hippocampi in drug-resistant TLE patients ^{2; 6; 7}. However, some patients have no MRI abnormalities in the standard MRI sequences ^{3; 17}. In these cases, new MRI techniques, such as MTR, could help improve the MRI detection of the epileptogenic focus. Our present study evaluated MTR in TLE patients with different hippocampal volumes on MRI, showing reduced MTR in the epileptogenic hippocampi. Moreover, in patients whose hippocampus showed normal volume, MTR were below normal values in 50 %, thus indicating that in normal volume cases MTR could help define the epileptogenic hippocampus, and in two cases (8 % of TLE) only MTR was below normal levels. This finding agrees with previous data in which reduced MTR was seen in the hippocampus associated with seizure focus ³⁶, and indicates that MTR can help lateralize the focus in some cases.

The atrophy seen in the epileptogenic hippocampus was linked to the degree of neuron loss in the granule cell layer ⁶ but more consistently to neuron loss in the CA1 subfield ^{10; 37}. A previous study from our group also pointed out neuron loss in CA1, together with chondroitin sulfate levels in this subfield, as the most important factor for explaining hippocampal volume ²⁵. Reduced magnetization transfer has been linked with myelin and neuron (axonal) loss in multiple sclerosis ^{14; 22; 38}. An animal model of autoimmune encephalomyelitis further indicated that MTR reduction in regions of neuron loss is more evident than in those with only demyelination ²⁷. In TLE, neuron loss is believed to be associated with MTR reduction ¹⁵. However, a study with temporal cortex showed no correlation between neuronal population and MTR values ¹³. Our data indicate that neuron loss in CA3 is important for MTR reduction seen in TLE.

From the glial population evaluated with immunohistochemistry, only the activated microglia correlated with the hippocampal MTR. The glial reaction is a common finding in the hippocampus of drug-resistant TLE patients ^{18; 24; 25}. Gliosis often following the degree of neuronal loss and seizure severity ^{8; 19}. However, the glial reaction is known to occur in the absence of neuron loss ³⁴. Increased T2 signal and relaxation time is often linked to reactive astrogliosis ^{6; 37}, whereas no MRI sequence so far has been directly linked to microglia ^{1; 12; 20}. We saw negative correlations between MTR and activated microglia, but not with reactive astrocytes. Given the usually low increase in activated microglia in the hippocampus when compared to the often exuberant neuron loss and astroglial reaction, it would be unexpected for microglia to affect MRI sequences. It is possible that the inverse correlation between microglia and MTR is an indirect effect from the stronger association between neuron loss and CSPG with MTR. In fact, when added to the multiple linear regression model that included CA3 and CA1 values, the activated microglia presents the highest VIF values (2.935 for CA3 and 4.037 for CA1), indicating multicollinearity between microglia and other factors. Thus, we believe activated microglia should be seen as an indirect indicator for MTR changes.

Extracellular matrix in the central nervous system is often studied concerning tissue plasticity ^{16; 32}. Increased CSPG levels were already described in patients with epilepsy and animal models ^{26; 30}. In the pathology/MRI correlation field, some studies have shown an association between apparent diffusion coefficient changes and increased levels of CSPG ^{28; 39}. Given that extracellular matrix accounts for 20 % of the brain parenchyma ^{9; 33}, it is expected that these molecules are important for MRI changes. In fact, previous studies of our group with hippocampi of TLE patients have shown a significant association between CSPG and changes in hippocampal volume and T2 relaxation ^{24; 25}. The link between extracellular matrix molecules and magnetization transfer is underexplored, and studies have provided mixed results. In phantoms of collagen and CSPG, while a study showed no correlation CSPG and MTR ³¹, another one has shown a weak positive association between CSPG and MTR ²¹. Studies with animal cartilage also indicated that MTR is more often affected by the amount of collagen, with little effect of CSPG ^{21; 35}. Our present data indicate that hippocampal MTR is strongly associated with the levels of CSPG. Moreover, our 3D scatterplots allow the visualization of a complex scenario where some patients with normal MTR have both higher neuron density and CSPG content, whereas other have high CSPG and low neuron density or, less frequently, low CSPG and higher neuron density (see Supplementary Figures 1 and 2). In a previous study, we also saw similar indications that some patients with severe neuron loss can have a high content of CSPG and, thus, a normal hippocampal volume ²⁵. In summary, the presence of normal hippocampal MTR should not rule out the occurrence of hippocampal neuron loss and, thus, hippocampal sclerosis.

The most important limitation of the present study is, in our view, that we only evaluated extracellular matrix with a broad-spectrum anti-chondroitin sulfate antibody, when it would be important to evaluate CSPG subtypes that also have important effects on tissue excitability, such as phosphacan (the molecules that compose the perineuronal nets) and neurocan, as well as hyaluronic acid. However, these molecules are better evaluated with western blot, which was not feasible for our samples. Moreover, it would be interesting to investigate larger series, especially with more patients with HS type 2, to evaluate the possible importance of MTR in separating HS type 1 and 2. These HS types are usually not distinguishable in presurgical MRI but can be identified in high-field ex-vivo MRI with smaller voxel size ²³. Even if more HS type 1 cases where added, we believe stronger associations would emerge. Another critical problem of the MRI-histology correlational studies that is often not discussed is the problem of associating variables of different dimensionalities (i.e., one-mm-thick MRI signal of whole hippocampal data with eight-µm-thin slices of immunohistochemistry evaluated in ROIs of different subfields). If replaced by whole-hippocampus western blot, we would lose subfields variability but the general picture would be closer to whole hippocampal MTR values. The problem of comparing variables of different dimensions, as far as we know, has no clear, widely accepted solution. A better approach for future studies could be through immunohistochemistry evaluation of the hippocampal subfields on several slices throughout the hippocampus long axis and compare it with discrete MTR values of each subfield, and enrich the data with molecular approaches such as western blot and proteomics. Higher-field MRI with smaller voxels could also improve correlational studies.

5. Conclusions

The present study indicates that neuron density and extracellular matrix chondroitin sulfate are associated with MTR changes in the hippocampi of TLE patients, and together can explain more than 70% of the MTR signal in the ipsilateral hippocampus.

Key Points

. In 64 % of patients with normal hippocampal volume on MRI, the combination of reduced magnetization transfer ratio and increased T2 relaxation indicates the epileptogenic hippocampus

. Extracellular matrix chondroitin sulfate proteoglycans are the most relevant correlate to magnetization transfer ratio in hippocampal sclerosis

. Increased chondroitin sulfate in the hippocampus can counterbalance the effect of neuron loss over the reduction in hippocampal magnetization transfer

Author Contributions

conceptualization, J.E.P.S., C.E.G.S., A.C.S., J.P.L.; formal analysis, J.E.P.S., G.H.S.R., T.R.V; investigation, J.E.P.S., G.H.S.R.; resources, C.G.C., J.A.A., K.K., R.C., I.B., C.E.G.S., A.C.S., J.P.L.; writing—original draft preparation, J.E.P.S.; writing—review and editing, J.E.P.S., J.P.L.; project administration, J.P.L.; funding acquisition, J.E.P.S, J.P.S.

Funding

This research was funded by Fundacao de Amaparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers 2015/20840-9 and 2016/17882-4.